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Abstract It has previously been shown that the transient
kinetics of the interaction between the Ras-binding domain of
c-Raf-1 and the proto-oncoprotein Ras can be followed by
stopped-flow measurements using the 2P,3P-(N-methylanthranil-
oyl) fluorescence of 2P,3P-(N-methylanthraniloyl) guanyl-5P-yl-
imidodiphosphate-labelled Ras. In continuation of this work, we
demonstrate that the His-tagged Ras-binding domain of c-Raf-1
can also be synthesized in a cell-free expression system. After
purification by Ni2+ affinity chromatography, His-tagged Ras-
binding domain of c-Raf-1 could be isolated in sufficient amounts
for biochemical and biophysical investigations. The results
obtained describe the first example of a cell-free synthesized
protein which has been used for stopped-flow measurements to
determine the transient kinetics of protein-protein interactions
with an effector.
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1. Introduction
The e⁄ciency and range of applications of protein synthesis
by cell-free expression has recently been considerably im-
proved and the technique is now established as a versatile
method with wide ranging applications in the biological sci-
ences. A number of di¡erent in vitro systems have been de-
veloped which utilize a variety of cell extracts, such as those
from E. coli or wheat germ. Furthermore, di¡erent experimen-
tal setups or protocols have been used to increase the yields
[1^3]. On an analytical scale, in vitro expression or translation
has been applied to, for example, the study of protein biosyn-
thesis. On the other hand, examples of synthesis on a prepar-
ative scale using this technology are still quite rare. In this
context, the development of continuous £ow cell-free (CFCF)
or semi-continuous systems is an important improvement
[4,5]. Another interesting application is in vitro suppression,
where proteins with arti¢cial amino acids can be synthesized
in a cell-free system [6]. However, the relative and absolute
amounts of in vitro synthesized proteins in a batch system are
still quite low when compared to bacterial expression systems,
which leads to di⁄culties in their puri¢cation. Hence, there
are only a few examples of cell-free synthesized proteins which
have been puri¢ed for further biophysical investigations (e.g.
[7^9]).
A general strategy to tackle the problem of yields in the Wg
scale is the use of an e⁄cient puri¢cation by a⁄nity chroma-
tography, e.g. by using the strep-tag or the His-tag. In pre-
vious work, we have shown that the His-tagged Ras-binding
domain (RBD/H) of c-Raf-1 can be puri¢ed by Ni2 a⁄nity
chromatography to homogeneity [10]. Furthermore, as an im-
portant prerequisite for a meaningful analysis of the biochem-
ical and biophysical properties, this C-terminal His-tag has
only a negligible in£uence on the interaction with H-Ras
[10]. Another important point is the experimental design of
the biophysical investigations, which must be adjusted to the
small amounts of the studied protein.
In this work, RBD/H was synthesized in a cell-free (Esche-
richia coli) batch system. Its binding to the proto-oncoprotein
Ras was followed by stopped-£ow measurements and the data
have been ¢tted by numerical simulation to satisfy the lower
than usual number of data sets. This example demonstrates
that the cell-free synthesis of proteins can be used for the
elucidation of biologically important questions such as the
interaction of Ras with a downstream e¡ector.
2. Materials and methods
The S30 extract was prepared from the E. coli strain D10 as de-
scribed [11]. For the expression of RBD/H under the control of the T7
promoter, the encoding gene was cloned from the pET vector which
was used for expression in E. coli [10] into the high copy plasmid
pUCBM20 together with the T7 promoter region. For in vitro expres-
sion, the DNA template was linearized by restriction with AatII, 470
bp downstream of the rbd/h gene.
Cell-free expression was optimized and performed as described [11]
on a 30 Wl or 1 ml scale. T7 RNA polymerase was prepared according
to the published procedure [12]. The reaction mixture contained 4 Wl
1 Wg/Wl AatII-linearized DNA template in diethylpyrocarbonate-H2O,
4 Wl 0.1 M Mg(OAc)2, 0.5 Wl 10 mg/ml rifampicin in 10% (v/v) MeOH,
7.7 Wl low molecular weight mix [11] (+1.5 Wl pyruvate kinase (2
U/Wl)+1 Wl RNAse inhibitor in 100 Wl), 1.4 Wl protease inhibitor
mix, 9 Wl S30 extract, 2.4 Wl 315 WM [14C]leucine in 2% (v/v) EtOH
(700 dpm/pmol), 1 Wl T7 RNA polymerase (60 U/Wl).
The amount of synthesized protein was determined after trichloro-
acetic acid precipitation by measuring the radioactivity of the incor-
porated [14C]leucine in a scintillation counter. [14C]leucine was ob-
tained from ICN Biomedicals (Eschwege).
SDS-PAGE was performed as described [13] and £uorography ac-
cording to [14]. The N-terminal sequence of the cell-free expressed
RBD/H was determined by Edman degradation after blotting of the
puri¢ed protein onto a polyvinylidene di£uoride (PVDF) membrane.
The protein concentration was determined using the Bradford assay
[15].
The synthesized RBD/H was puri¢ed from the cell-free batch sys-
tem by Ni2 a⁄nity chromatography using the Ni2-NTA spin kit
from Qiagen (Hilden). The samples (1 ml) were centrifuged for 10 min
at 8‡C and ¢ltered over a Low Binding Durapore membrane (Milli-
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pore). The ¢ltrate (3 ml) was loaded onto a Ni2-NTA spin column
(3 ml/column) which was previously equilibrated with bu¡er A
(300 mM NaCl, 50 mM phosphate, 5 mM imidazole, pH 8). The
column was washed three times with bu¡er A and three times with
bu¡er B (A with 20 mM imidazole). RBD/H was eluted by increasing
the imidazole concentrations to 200 mM. In all steps, the columns
were centrifuged at 150Ug for about 2 min. The combined fractions
were concentrated with centrifugal concentrators from Filtron Tech-
nology and used directly for the stopped-£ow measurements.
Stopped-£ow measurements, numerical simulation and ¢tting of the
data sets to a kinetic model were performed as described [10].
3. Results and discussion
The cell-free synthesis of RBD/H was performed in a batch
system with S30 extracts from E. coli. For the expression of
the rbd/h gene, we used the T7 promoter which has already
been widely used for selective expression in bacterial cell-free
systems [16,17]. The subcloning of the encoding gene of the
RBD/H into the high-copy plasmid pUCBM20 provided high
yields of the required plasmid. The additional His-tag at the
C-terminus allows the subsequent puri¢cation of the synthe-
sized protein by Ni2 a⁄nity chromatography.
Finally, an expression yield of 40 Wg/ml was obtained. Anal-
ysis by £uorography showed that only one protein with a
molecular weight in the range expected for RBD/H was syn-
thesized (Fig. 1, lane 2). Its broad band is due to the high
protein concentration of the sample. The positions of the
marker bands and that of the authentic RBD/H have been
indicated by bars.
In the next step, RBD/H was puri¢ed by Ni2 a⁄nity chro-
matography. For small amounts of a His-tagged protein, the
spin kit system from Qiagen is especially suited, since the spin
columns have a lower binding capacity compared to Ni2-
NTA agarose and they are easy to handle. After centrifuga-
tion and ¢ltration of the cell-free expression samples, a total
of 3 ml was loaded onto one column. After washing with 5 and
20 mM imidazole, the RBD/H was eluted with 200 mM
imidazole. Fig. 2 shows the SDS-PAGE analysis of the puri-
¢cation steps. The protein bands were visualized by Coomas-
sie blue staining. Most of the impurities could be eluted with
bu¡er A (Fig. 2, lane 4). Increasing the imidazole concentra-
tion to 20 mM in the wash bu¡er (bu¡er B) only led to the
elution of minor impurities in the higher molecular weight
range (Fig. 2, lane 5). Lane 6 and 7 show puri¢ed RBD/H
from two di¡erent Ni2-NTA spin columns. As can be seen,
only minor impurities (mostly in the high molecular weight
range) contaminate the RBD/H samples. From 3 ml cell-free
extracts, about 90 Wg RBD/H (75% recovered yield based on
synthesized protein) could be obtained, which was su⁄cient
for the subsequent biophysical analysis.
The puri¢ed protein was analyzed by SDS-PAGE, blotted
onto a PVDF membrane and N-terminally sequenced by Ed-
man degradation. The determined sequence (DPSKT) is in
accordance with the N-terminal sequence of the RBD. Fi-
nally, the protein samples were concentrated and used directly
for stopped-£ow measurements using the conditions previ-
ously described [10].
In these experiments, we used H-Ras loaded with the £uo-
rescent, non-hydrolyzable GTP analogue 2P,3P-(N-methylan-
thraniloyl) (mant) guanyl-5P-yl-imidodiphosphate (GppNHp).
Thus, the interaction of RBD/H with this complex can be
followed by a change of the mant £uorescence. The kinetics
of this process are in the ms^s time range and could thus be
investigated by the stopped-£ow method. However, the small
amount of the cell-free expressed RBD/H available for these
experiments did not allow a variation of the concentration
under pseudo-¢rst order conditions. Therefore, a di¡erent ap-
proach for the determination of kinetic parameters was chos-
en.
Assuming the simplest model (one step binding: Scheme 1),
the di¡erential equations were integrated numerically and
constants were ¢tted to this model using two di¡erent data
sets obtained at di¡erent RBD/H concentrations. This was
performed with the program Scientist and a single set of con-
stants was obtained which were compatible with both data
sets. The model equation ¢le for the simultaneous ¢t of two
£uorescence transients is presented in Scheme 2.
Scheme 1.
Scheme 2.
C and C1 are the concentrations of the H-Ras.mant-
GppNHp.RBD/H complex in the two experiments with the
unit WM, F and F1 are the observed £uorescence signals
(photomultiplier output in volts), k1 and k2 are the rate con-
stants for the forward (k1) and reverse reactions (k2) with the
Fig. 1. Analysis of an optimized cell-free synthesis of RBD/H by
£uorography. Lane 1: bars indicate the positions of the PMW
marker bands on the corresponding polyacrylamide gel, lane 2: 5 Wl
of a cell-free expression sample, incubated at 37‡C for 1 h with L-
[14C]leucin, lane 3: the single bar indicates the position of the RBD/
H band expressed in E. coli as a reference on the corresponding
polyacrylamide gel, lane 4: negative control (cell-free expression
sample without T7 RNA polymerase)
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units WM/s and s31, respectively, Ya and Yc are the £uores-
cence yields with the units V/WM and A0 and B0 are the initial
concentrations of H-Ras.mantGppNHp and RBD/H, respec-
tively, also with the unit WM. CP and C1P stand for dC/dt and
dC1/dt.
The concentrations of proteins were allowed to £oat during
the ¢t procedure to determine the concentration of active cell-
free synthesized protein (Scheme 2).
In our ¢rst experiment, we obtained two data sets for the
interaction of 0.5 WM H-Ras.mantGppNHp with di¡erent
concentrations (0.5 and 1 WM) of RBD/H expressed in E.
coli to verify this approach to the determination of the kinetic
parameters by comparison with the previously determined
values of the E. coli-expressed protein (Fig. 3a). The kinetic
parameters for the interaction of the two proteins which result
from the numerical simulation are in very good agreement
with the previously obtained data from the pseudo-¢rst order
measurements and give a dissociation constant of 0.3 WM
[10]:
k1 = 2.3U107 M31/s Ya = 1.93 V/WM A0 = 0.51 WM
k2 = 6.8 s31 Yc = 1.77 V/WM B0 = 0.47 WM
where A is H-Ras.mantGppNHp, B is RBD/H, Ya is the
£uorescence yield of H-Ras.mantGppNHp and Yc is the £uo-
rescence yield of the complex.
Furthermore, the concentrations which were determined by
the simulation correlate very well with the concentrations de-
termined by a protein assay (0.5 WM for H-Ras.mant-
GppNHp, 0.5 and 1 WM for RBD/H).
The ¢t for the interaction of 0.5 WM H-Ras.mantGppNHp
with di¡erent concentrations (0.58 and 1.16 WM) of the cell-
free synthesized RBD/H is shown in Fig. 3b.
The numerical simulation with the model presented in
Scheme 2 gave the following results for the parameters :
k1 = 1.7U107 M31/s Ya = 2.07 V/WM A0 = 0.48 WM
k2 = 5.9 s31 Yc = 1.94 V/WM B0 = 0.50 WM
The rate constants appear to be slightly reduced compared
to the RBD/H expressed in E. coli but they are still in the
same range, i.e. ca. 2U107 M31/s for the association rate
constant and ca. 6 s31 for the dissociation rate constant.
The determined dissociation constant for the ternary complex
is 0.34 WM, which is also in good agreement with the Kd value
for the RBD/H expressed in E. coli.
Another aspect is also very important in this case. The
simultaneous simulation of the data sets allows determination
of the e¡ective concentration (0.5 WM) of the RBD/H, which
is about 15% lower for the cell-free synthesized protein than
determined by a protein assay (0.58 WM). This correlates with
the SDS-PAGE analysis which shows some impurities in the
elution sample of the cell-free synthesized RBD/H. If these
contaminations are taken into consideration, the cell-free syn-
thesized protein has about the same degree of activity as the
RBD/H expressed in E. coli.
Our work presents an illustrative example that cell-free syn-
thesized proteins are now readily amenable for biochemical
and biophysical studies like stopped-£ow techniques. How-
ever, an e⁄cient puri¢cation scheme, such as a⁄nity chroma-
tography, and special approaches for dealing with small
amounts of protein are still mandatory. This procedure can
certainly be extended to the analysis of protein-protein inter-
actions with £uorescently labelled proteins which have been
synthesized by in vitro suppression.
Fig. 2. SDS-PAGE analysis of the RBD/H puri¢cation synthesized
in the cell-free expression system. Lane 1: PMW marker, lane 2:
5 Wl of a cell-free expression sample, incubated at 37‡C for 1 h,
lane 3: 5 Wl £ow-through of the Ni2-NTA spin column, lane 4:
50 Wl of the washing pool of bu¡er A, lane 5: 50 Wl of the washing
pool of bu¡er B, lane 6 and 7: elution pools of two di¡erent Ni2-
NTA spin columns. All samples were precipitated with acetone and
redissolved in sample bu¡er.
Fig. 3. (a) Simultaneous ¢t of the £uorescence transients using the
described model equation ¢le (scheme 2) with the program Scientist
for the RBD/H expressed in E. coli. 0.5 WM H.Ras.mantGppNHp
was rapidly mixed with 0.5 WM and 1 WM RBD/H at 25‡C. The ex-
citation wavelength was 366 nm with detection through a 389 nm
cut-o¡ ¢lter. (b) Simultaneous ¢t of the £uorescence transients using
the described model with the program Scientist for the cell-free syn-
thesized RBD/H. The same conditions as described above with
0.58 WM and 1.16 WM cell-free synthesized RBD/H.
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